Knowledge, attitudes, and practices of the general population, herpes zoster patients, and dermatologists toward herpes zoster in China: A quantitative cross-sectional survey

References

• Centers for Disease Control and Prevention. The Pink Book: Zoster. 2021 Aug 18 [accessed 2022 Mar]. https://www.cdc.gov/vaccines/pubs/pinkbook/herpes-zoster.html.
   Google Scholar
• Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, Labetoulle M, Michel JP, Naldi L, Sanmarti LS, Weinke T. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 2015;3:109–13. doi:10.1177/2051013615599151.
   PubMedGoogle Scholar
• Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8:37. doi:10.1186/1741-7015-8-37.
   PubMed Web of Science ®Google Scholar
• Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis. 2004;39:342–8. doi:10.1086/421942.
   PubMed Web of Science ®Google Scholar
• Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P, Chan IS, Choo P, Levin MJ, Johnson G, Williams HM, Oxman MN. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain. 2007;23(6):490–6. doi:10.1097/AJP.0b013e318065b6c9.
   PubMed Web of Science ®Google Scholar
• Yu SY, Fan BF, Yang F, DiBonaventura M, Chen YX, Li RY, King-Concialdi K, Kudel I, Hlavacek P, Hopps M, Udall M, Sadosky A, Cappelleri JC. Patient and economic burdens of postherpetic neuralgia in China. Clin Outcomes Res. 2019;11:539–50. doi:10.2147/CEOR.S203920.
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, Roos LL, DE Serres G. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001;127:305–14. doi:10.1017/S0950268801005921.
   PubMed Web of Science ®Google Scholar
• Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2008;57 quiz CE2–4:1–30.
   PubMedGoogle Scholar
• Lin YH, Huang LM, Chang IS, Tsai F-Y, Lu C-Y, Shao P-L, Chang L-Y. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine. 2010;28:1217–20. doi:10.1016/j.vaccine.2009.11.029.
   PubMed Web of Science ®Google Scholar
• National Bureau of Statistics. Bulletin for the 7th census of China (5th Edition). 2021 May 11 [accessed 2022 Mar]. http://www.stats.gov.cn/sj/tjgb/rkpcgb/qgrkpcgb/202302/t20230206_1902005.html.
   Google Scholar
• Fang EF, Scheibye-Knudsen M, Jahn HJ, Li J, Ling L, Guo H, Zhu X, Preedy V, Lu H, Bohr VA, Chan WY, Liu Y, Ng TB. A research agenda for aging in China in the 21st century. Ageing Res Rev. 2015;24:197–205. doi:10.1016/j.arr.2015.08.003.
   PubMed Web of Science ®Google Scholar
• Li Y, An Z, Yin D, Liu Y, Huang Z, Xu J, Ma Y, Tu Q, Li Q, Wang H. Disease burden due to herpes zoster among population aged ≥50 years old in China: a community based retrospective survey. PLoS One. 2016;11(4):e0152660. doi:10.1371/journal.pone.0152660.
   PubMed Web of Science ®Google Scholar
• Sun X, Wei Z, Lin H, Jit M, Li Z, Fu C. Incidence and disease burden of herpes zoster in the population aged ≥50 years in China: data from an integrated health care network. J Infect. 2021;82:253–60. doi:10.1016/j.jinf.2020.12.013.
   PubMed Web of Science ®Google Scholar
• Yin D, Van Oorschot D, Jiang N, Marijam A, Saha D, Wu Z, Tang H, Diaz-Decaro J, Watson P, Xie X, Ren Y, He Y, Feng Y. A systematic literature review to assess the burden of herpes zoster disease in China. Expert Rev Anti Infect Ther. 2021;19(2):165–79. doi:10.1080/14787210.2020.1792290.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zheng H, Qu H, Deng H, Zhang J, Ma W, Lin Y, Xie X, Qiu Q, Huang Z. Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China. Hum Vaccin Immunother. 2015;11:2113–8. doi:10.1080/21645515.2015.1016672.
   PubMed Web of Science ®Google Scholar
• Shi J, Gao C, Yu P. Interpretation of core information on disability prevention in the elderly. Chinese J Geriatr. 2019;38:1077–8.
   Google Scholar
• Chen L-K, Arai H, Chen L-Y, Chou M-Y, Djauzi S, Dong B, Kojima T, Kwon KT, Leong HN, Leung EMF, Liang C-K, Liu X, Mathai D, Pan JY, Peng L-N, Poblete ERS, Poi PJH, Reid S, Tantawichien T, Won CW. Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. BMC Infect Dis. 2017;17(1):213. doi:10.1186/s12879-017-2198-y.
   PubMedGoogle Scholar
• National Medical Products Administration of the People’s Republic of China. Herpes zoster vaccine (recombinant, adjuvanted). 2019 May 22 [accessed 2022 Mar]. https://www.nmpa.gov.cn/directory/web/nmpa/zhuanti/ypqxgg/gggzjzh/20190522150701437.html.
   Google Scholar
• Wang F, Zhang W, Tang F, Lu H, Sun L, Qi Q, Hao F, Wang H, Yin Z. Interpretation of shingles vaccination guidelines of the advisory committee on immunization practices in the United States and Canada. Chin Med J. 2021;101:363–8. doi:10.3760/cma.j.cn112137-20201030-02968.
   Google Scholar
• Wang M, Hu M, Wang Y, Long C, Xia Y, Zhu D, Zhao W, Yuan B, He P. Willingness to vaccinate against herpes zoster in Chinese urban population: a mixed-methods study. BMJ Open. 2023;13:e079115. doi:10.1136/bmjopen-2023-079115.
   PubMed Web of Science ®Google Scholar
• Lam AC, Chan MY, Chou HY, Ho SY, Li HL, Lo CY, Shek KF, To SY, Yam KK, Yeung I. A cross-sectional study of the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster in an out-patient setting. Hong Kong Med J. 2017;23:365–73. doi:10.12809/hkmj165043.
   PubMed Web of Science ®Google Scholar
• Wang M, Long C, Hu MZ, Wang YS, Xia YQ, Yuan BB, Zhu DW, He P. A study on knowledge, attitude, and vaccination behavior of herpes zoster vaccine among urban residents in selected areas of China. Zhonghua Liu Xing Bing Xue Za Zhi. 2023;44:899–904. doi:10.3760/cma.j.cn112338-20221125-00998.
   PubMedGoogle Scholar
• Lee C, Giannelos N, Curran D, Dong H, Tang H, Jiang N, Ye C, Yuan Y, Ng C. Lifetime risk of herpes zoster in the population of Beijing, China. Public Health Pract. 2023;5:100356. doi:10.1016/j.puhip.2023.100356.
   Google Scholar
• Cheng L-Y. A pilot study to assess the awareness of herpes zoster and the attitudes towards herpes zoster vaccination among Chinese patients attending a government general out-patient clinic in Hong Kong. HK Pract. 2019;41:60–5.
   Google Scholar
• Yang TU, Cheong HJ, Song JY, Noh JY, Kim WJ. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea. Hum Vaccin Immunother. 2015;11:719–26. doi:10.1080/21645515.2015.1008885.
   PubMed Web of Science ®Google Scholar
• Bricout H, Torcel-Pagnon L, Lecomte C, Almas MF, Matthews I, Lu X, Wheelock A, Sevdalis N. Determinants of shingles vaccine acceptance in the United Kingdom. PLoS One. 2019;14:e0220230. doi:10.1371/journal.pone.0220230.
   PubMed Web of Science ®Google Scholar
• Baalbaki NA, Fava JP, Ng M, Okorafor E, Nawaz A, Chiu W, Salim A, Cha R, Kilgore PE. A community-based survey to assess knowledge, attitudes, beliefs and practices regarding herpes zoster in an urban setting. Infect Dis Ther. 2019;8:687–94. doi:10.1007/s40121-019-00269-2.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Shingles (Herpes Zoster). 2023 May 10 [accessed 2023 Jul]. https://www.cdc.gov/shingles/about/treatment.html.
   Google Scholar
• British Association of Dermatologists: Shingles (herpes zoster) PIL. 2020 May [accessed 2023 Jul]. https://www.bad.org.uk/pils/shingles-herpes-zoster/.
   Google Scholar
• Jiang Y, Zheng RX, Yu ZY, Zhang XW, Li J, Lan HD, Qiao SY, Han M, Cao HJ, Robinson N, Liu JP. Traditional Chinese medicine for HIV-associated acute herpes zoster: a systematic review and meta-analysis of randomized trials. Evid Based Complementary Altern Med. 2022;2022:1–12. doi:10.1155/2022/8674648.
   Web of Science ®Google Scholar
• Forsberg IN, Comrie RW, Jenkins D, Jezuit D. Educational strategies to improve herpes zoster vaccination in older adults. J Health Commun. 2018;3:35. doi:10.4172/2472-1654.100145.
   Google Scholar
• Hurley LP, Lindley MC, Harpaz R, Stokley S, Daley MF, Crane LA, Dong F, Beaty BL, Tan L, Babbel C, Dickinson LM, Kempe A. Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010;152:555–60. doi:10.7326/0003-4819-152-9-201005040-00005.
   PubMed Web of Science ®Google Scholar
• Lu X, Lu J, Zhang F, Wagner AL, Zhang L, Mei K, Guan B, Lu Y. Low willingness to vaccinate against herpes zoster in a Chinese metropolis. Hum Vaccin Immunother. 2021;17:4163–70. doi:10.1080/21645515.2021.1960137.
   PubMed Web of Science ®Google Scholar
• Herpes Zoster Expert Consensus Working Group of Chinese Dermatologist Association. Consensus of Chinese experts on herpes zoster. Chin J Dermatol. 2018;51:403–8. doi:10.3760/cma.j.issn.0412-4030.2018.06.001.
   Google Scholar